vs
IONIS PHARMACEUTICALS INC（IONS）与ROGERS CORP（ROG）财务数据对比。点击上方公司名可切换其他公司
IONIS PHARMACEUTICALS INC的季度营收约是ROGERS CORP的1.0倍（$203.3M vs $200.5M），ROGERS CORP净利率更高（2.2% vs -112.8%，领先115.1%），ROGERS CORP同比增速更快（5.2% vs -10.3%），ROGERS CORP自由现金流更多（$1.1M vs $-159.0M），过去两年IONIS PHARMACEUTICALS INC的营收复合增速更高（30.4% vs -3.3%）
IONIS制药是1989年成立的生物科技企业，总部位于美国加利福尼亚州卡尔斯巴德，专注于反义疗法、RNA干扰及CRISPR疗法的研发，2015年12月前曾以Isis制药的名称运营。
罗杰斯公司是一家专注于特种工程材料研发生产的企业，总部位于美国亚利桑那州钱德勒市，其产品广泛应用于先进电子、移动通信、清洁能源、航空航天等多个高科技领域，为全球客户提供高性能材料解决方案。
IONS vs ROG — 直观对比
营收规模更大
IONS
是对方的1.0倍
$200.5M
营收增速更快
ROG
高出15.5%
-10.3%
净利率更高
ROG
高出115.1%
-112.8%
自由现金流更多
ROG
多$160.1M
$-159.0M
两年增速更快
IONS
近两年复合增速
-3.3%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $203.3M | $200.5M |
| 净利润 | $-229.4M | $4.5M |
| 毛利率 | 96.1% | 32.2% |
| 营业利润率 | -105.5% | — |
| 净利率 | -112.8% | 2.2% |
| 营收同比 | -10.3% | 5.2% |
| 净利润同比 | -119.8% | 421.4% |
| 每股收益（稀释后） | $-1.35 | $0.25 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收IONSROG
| Q1 26 | — | $200.5M | ||
| Q4 25 | $203.3M | $201.5M | ||
| Q3 25 | $156.7M | $216.0M | ||
| Q2 25 | $452.0M | $202.8M | ||
| Q1 25 | $131.6M | $190.5M | ||
| Q4 24 | $226.6M | $192.2M | ||
| Q3 24 | $133.8M | $210.3M | ||
| Q2 24 | $225.3M | $214.2M |
净利润IONSROG
| Q1 26 | — | $4.5M | ||
| Q4 25 | $-229.4M | $4.6M | ||
| Q3 25 | $-128.6M | $8.6M | ||
| Q2 25 | $123.6M | $-73.6M | ||
| Q1 25 | $-146.9M | $-1.4M | ||
| Q4 24 | $-104.3M | $-500.0K | ||
| Q3 24 | $-140.5M | $10.7M | ||
| Q2 24 | $-66.3M | $8.1M |
毛利率IONSROG
| Q1 26 | — | 32.2% | ||
| Q4 25 | 96.1% | 31.5% | ||
| Q3 25 | 98.5% | 33.5% | ||
| Q2 25 | 99.1% | 31.6% | ||
| Q1 25 | 98.9% | 29.9% | ||
| Q4 24 | 98.3% | 32.1% | ||
| Q3 24 | 99.2% | 35.2% | ||
| Q2 24 | 98.2% | 34.1% |
营业利润率IONSROG
| Q1 26 | — | — | ||
| Q4 25 | -105.5% | 3.5% | ||
| Q3 25 | -102.2% | 7.3% | ||
| Q2 25 | 30.9% | -33.3% | ||
| Q1 25 | -111.6% | -0.2% | ||
| Q4 24 | -48.9% | -6.6% | ||
| Q3 24 | -111.1% | 6.9% | ||
| Q2 24 | -29.3% | 5.3% |
净利率IONSROG
| Q1 26 | — | 2.2% | ||
| Q4 25 | -112.8% | 2.3% | ||
| Q3 25 | -82.1% | 4.0% | ||
| Q2 25 | 27.3% | -36.3% | ||
| Q1 25 | -111.6% | -0.7% | ||
| Q4 24 | -46.1% | -0.3% | ||
| Q3 24 | -105.0% | 5.1% | ||
| Q2 24 | -29.4% | 3.8% |
每股收益（稀释后）IONSROG
| Q1 26 | — | $0.25 | ||
| Q4 25 | $-1.35 | $0.20 | ||
| Q3 25 | $-0.80 | $0.48 | ||
| Q2 25 | $0.70 | $-4.00 | ||
| Q1 25 | $-0.93 | $-0.08 | ||
| Q4 24 | $-0.66 | $-0.04 | ||
| Q3 24 | $-0.95 | $0.58 | ||
| Q2 24 | $-0.45 | $0.44 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $2.7B | $195.8M |
| 总债务越低越好 | $1.8B | — |
| 股东权益账面价值 | $489.1M | $1.2B |
| 总资产 | $3.5B | $1.4B |
| 负债/权益比越低杠杆越低 | 3.71× | — |
8季度趋势，按日历期对齐
现金及短期投资IONSROG
| Q1 26 | — | $195.8M | ||
| Q4 25 | $2.7B | $197.0M | ||
| Q3 25 | $2.2B | $167.8M | ||
| Q2 25 | $2.3B | $157.2M | ||
| Q1 25 | $2.1B | $175.6M | ||
| Q4 24 | $2.3B | $159.8M | ||
| Q3 24 | $2.5B | $146.4M | ||
| Q2 24 | $2.1B | $119.9M |
总债务IONSROG
| Q1 26 | — | — | ||
| Q4 25 | $1.8B | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $1.3B | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
股东权益IONSROG
| Q1 26 | — | $1.2B | ||
| Q4 25 | $489.1M | $1.2B | ||
| Q3 25 | $618.0M | $1.2B | ||
| Q2 25 | $631.7M | $1.2B | ||
| Q1 25 | $475.7M | $1.3B | ||
| Q4 24 | $588.4M | $1.3B | ||
| Q3 24 | $662.5M | $1.3B | ||
| Q2 24 | $263.7M | $1.3B |
总资产IONSROG
| Q1 26 | — | $1.4B | ||
| Q4 25 | $3.5B | $1.4B | ||
| Q3 25 | $3.0B | $1.4B | ||
| Q2 25 | $3.0B | $1.5B | ||
| Q1 25 | $2.8B | $1.5B | ||
| Q4 24 | $3.0B | $1.5B | ||
| Q3 24 | $3.1B | $1.5B | ||
| Q2 24 | $2.7B | $1.5B |
负债/权益比IONSROG
| Q1 26 | — | — | ||
| Q4 25 | 3.71× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 2.13× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-137.7M | $5.8M |
| 自由现金流经营现金流 - 资本支出 | $-159.0M | $1.1M |
| 自由现金流率自由现金流/营收 | -78.2% | 0.5% |
| 资本支出强度资本支出/营收 | 10.5% | 2.3% |
| 现金转化率经营现金流/净利润 | — | 1.29× |
| 过去12个月自由现金流最近4个季度 | $-320.0M | $70.1M |
8季度趋势，按日历期对齐
经营现金流IONSROG
| Q1 26 | — | $5.8M | ||
| Q4 25 | $-137.7M | $46.9M | ||
| Q3 25 | $-131.4M | $28.9M | ||
| Q2 25 | $151.3M | $13.7M | ||
| Q1 25 | $-150.8M | $11.7M | ||
| Q4 24 | $-116.1M | $33.7M | ||
| Q3 24 | $-115.0M | $42.4M | ||
| Q2 24 | $-119.9M | $22.9M |
自由现金流IONSROG
| Q1 26 | — | $1.1M | ||
| Q4 25 | $-159.0M | $42.2M | ||
| Q3 25 | $-136.7M | $21.2M | ||
| Q2 25 | $139.0M | $5.6M | ||
| Q1 25 | $-163.4M | $2.1M | ||
| Q4 24 | $-141.6M | $18.3M | ||
| Q3 24 | $-124.0M | $25.2M | ||
| Q2 24 | $-126.1M | $8.8M |
自由现金流率IONSROG
| Q1 26 | — | 0.5% | ||
| Q4 25 | -78.2% | 20.9% | ||
| Q3 25 | -87.2% | 9.8% | ||
| Q2 25 | 30.8% | 2.8% | ||
| Q1 25 | -124.1% | 1.1% | ||
| Q4 24 | -62.5% | 9.5% | ||
| Q3 24 | -92.7% | 12.0% | ||
| Q2 24 | -56.0% | 4.1% |
资本支出强度IONSROG
| Q1 26 | — | 2.3% | ||
| Q4 25 | 10.5% | 2.3% | ||
| Q3 25 | 3.4% | 3.6% | ||
| Q2 25 | 2.7% | 4.0% | ||
| Q1 25 | 9.6% | 5.0% | ||
| Q4 24 | 11.3% | 8.0% | ||
| Q3 24 | 6.8% | 8.2% | ||
| Q2 24 | 2.8% | 6.6% |
现金转化率IONSROG
| Q1 26 | — | 1.29× | ||
| Q4 25 | — | 10.20× | ||
| Q3 25 | — | 3.36× | ||
| Q2 25 | 1.22× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 3.96× | ||
| Q2 24 | — | 2.83× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
IONS
| Products | $58.0M | 29% |
| Spinraza Royalties | $54.0M | 27% |
| Collaborative Agreement Revenue | $52.4M | 26% |
| Wainus Royalties | $16.0M | 8% |
| Wainua Joint Development Revenue | $9.6M | 5% |
| Other Commercial | $7.6M | 4% |
| Other Royalties | $5.7M | 3% |
ROG
暂无分部数据
